MedPath

Aleplasinin

Generic Name
Aleplasinin
Drug Type
Small Molecule
Chemical Formula
C28H27NO3
CAS Number
481629-87-2
Unique Ingredient Identifier
LL56J87F3X

Overview

Aleplasinin has been investigated in Alzheimer Disease.

Background

Aleplasinin has been investigated in Alzheimer Disease.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Study Evaluating PAZ-417 in Cerebrospinal Fluid in Subjects With Alzheimer's Disease
Phase 1
Terminated
Posted: 2008/08/21
Sponsor:
Wyeth is now a wholl...
ID:NCT00739037
Study Evaluating the Safety, Tolerability and Activity of One Dose of PAZ-417 Given to Healthy Japanese Subjects
Phase 1
Completed
Posted: 2008/05/28
Sponsor:
Wyeth is now a wholl...
ID:NCT00684710
A Study of the Safety of PAZ-417 in Healthy Elderly Adults
Phase 1
Terminated
Posted: 2008/04/21
Sponsor:
Wyeth is now a wholl...
ID:NCT00663065
Study Evaluating PAZ-417 in Healthy Young/Elderly
Completed
Posted: 2006/08/21
Sponsor:
Wyeth is now a wholl...
ID:NCT00366288

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy